Risk of thrombocytopenia with Platelet‐derived Growth Factor Receptor Kinase Inhibitors (PDGFR‐TKIs) in cancer patients: A systematic review and meta‐analysis of phase II/III randomized controlled trials

Author(s):  
Yuan Liu ◽  
Wenxia Sun ◽  
Jing Li
Sign in / Sign up

Export Citation Format

Share Document